Reaction Process: PlantCyc:PLANT_PWY18C3-10
triacylsucrose biosynthesis (Solanum) related metabolites
find 2 related metabolites which is associated with chemical reaction(pathway) triacylsucrose biosynthesis (Solanum)
2-methylbutanoyl-CoA + 3-dodecanoyl-4-(3-methylbutanoyl)sucrose ⟶ 3-dodecanoyl-3',4-di(3-methylbutanoyl)sucrose + coenzyme A
2-Methylbutyryl-CoA
2-Methylbutyryl-CoA (CAS: 6712-02-3), also known as alpha-methylbutyryl-coenzyme A, belongs to the class of organic compounds known as acyl-CoAs. These are organic compounds containing a coenzyme A substructure linked to an acyl chain. 2-Methylbutyryl-CoA is a strong basic compound (based on its pKa). 2-Methylbutyryl-CoA is a product of isoleucine catabolism. It is converted into tiglyl-CoA by short/branched-chain acyl-CoA dehydrogenase. 2-Methylbutyryl-CoA dehydrogenase deficiency, also known as 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency or MBHD, is an inherited disorder in which the body is unable to process the amino acid isoleucine properly. It is caused by a mutation in the HADH2 gene. Untreated MBHD can lead to progressive loss of motor skills, mental retardation, and epilepsy. a-Methylbutyryl-CoA is a a product of isoleucine catabolism. It is converted to Tiglyl-CoA by short/branched-chain acyl-CoA dehydrogenase. 2-Methylbutyryl-CoA dehydrogenase deficiency, also called 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency or MBHD, is an inherited disorder in which the body is unable to process the amino acid isoleucine properly. It is caused by a mutation in the HADH2 gene. Untreated MBHD can lead to progressive loss of motor skills, to mental retardation and to epilepsy. 2-Methylbutyryl-CoA is a substrate for Acyl-CoA dehydrogenase (short-chain specific, mitochondrial), Acyl-CoA dehydrogenase (medium-chain specific, mitochondrial) and Acyl-CoA dehydrogenase (long-chain specific, mitochondrial). [HMDB]
coenzyme A(4-)
C21H32N7O16P3S-4 (763.0839062)
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS